Page last updated: 2024-09-03

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and nan 190

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with nan 190 in 2 studies

Compound Research Comparison

Studies
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Trials
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Recent Studies (post-2010)
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Studies
(nan 190)
Trials
(nan 190)
Recent Studies (post-2010) (nan 190)
4209245033

Protein Interaction Comparison

ProteinTaxonomy4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine (IC50)nan 190 (IC50)
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.003

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audinot, V; Bervoets, K; Brocco, M; Canton, H; Gobert, A; Le Marouille-Girardon, S; Millan, MJ; Peglion, JL1
Bervoets, K; Brocco, M; Canton, H; Gobert, A; Lejeune, F; Millan, MJ; Peglion, JL; Rivet, JM; Widdowson, P1

Other Studies

2 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and nan 190

ArticleYear
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
    Journal of medicinal chemistry, 1995, Sep-29, Volume: 38, Issue:20

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Male; Piperazines; Rats; Rats, Wistar; Serotonin Antagonists; Structure-Activity Relationship

1995
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.
    European journal of pharmacology, 1993, Jan-05, Volume: 230, Issue:1

    Topics: Animals; Behavior, Animal; Blepharoptosis; Body Temperature; Brain Chemistry; Ligands; Male; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses

1993